1. Home
  2. SHEN vs CADL Comparison

SHEN vs CADL Comparison

Compare SHEN & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shenandoah Telecommunications Co

SHEN

Shenandoah Telecommunications Co

N/A

Current Price

$9.66

Market Cap

549.2M

ML Signal

N/A

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$8.70

Market Cap

641.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHEN
CADL
Founded
1902
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
549.2M
641.2M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
SHEN
CADL
Price
$9.66
$8.70
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
★ $27.50
$22.11
AVG Volume (30 Days)
734.3K
★ 1.0M
Earning Date
10-28-2026
11-16-2026
Dividend Yield
★ 1.13%
N/A
EPS Growth
N/A
★ 58.62
EPS
★ N/A
N/A
Revenue
★ $357,854,000.00
$125,000.00
Revenue This Year
$4.66
N/A
Revenue Next Year
$5.27
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 9.08
N/A
52 Week Low
$9.13
$4.35
52 Week High
$17.35
$14.00

Technical Indicators

Market Signals
Indicator
SHEN
CADL
Relative Strength Index (RSI) 38.03 46.63
Support Level $9.13 $7.70
Resistance Level $10.48 $9.42
Average True Range (ATR) 0.50 0.61
MACD 0.03 0.13
Stochastic Oscillator 40.89 62.27

Price Performance

Historical Comparison
SHEN
CADL

About SHEN Shenandoah Telecommunications Co

Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: